A Non Comparative Observational Study to Describe the Duration and Outcome of Treatment in Therapy naïve HIV Positive Patients Initiated on Atazanavir (ATV)/ Ritonavir (RTV)-Based Highly Active Antiretroviral Therapy (HAART) Regimens
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Atazanavir (Primary) ; Nucleoside reverse transcriptase inhibitors; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms REMAIN
- Sponsors Bristol-Myers Squibb
- 19 Oct 2013 Second interim analysis presented at the 14th European AIDS Conference.
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Sep 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.